• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 69 of 100
Democratic Presidential candidate and former U.S. Secretary of State Hillary Clinton Campaigns In Iowa
Leadership
Hillary Clinton Says You Won’t See Price Hikes On Life-Saving Drugs if She’s Elected
By ReutersSeptember 2, 2016
FRANCE-POLITICS-INDUSTRY
Health
U.S. Headwinds Force Change of CEO at Novo Nordisk
By ReutersSeptember 1, 2016
The Davos World Economic Forum 2015
Health
Novartis Just Got Some Great News in Its Battle for Amgen’s Market Share
By Sy MukherjeeAugust 31, 2016
Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion
Finance
Alere Is Suing to Force Abbott to Complete Their $5.8 Billion Merger
By ReutersAugust 26, 2016
US-HEALTH-DRUGS-CONSUMER-POLITICS-MYLAN
Finance
What Mylan’s EpiPen Cost Scandal Says About the Drug Price Problem
By Jen WiecznerAugust 25, 2016
Fortune Most Powerful Women Summit 2015
Health
Mylan Halves EpiPen Price After Being Savaged by Clinton
By Reuters and Fortune EditorsAugust 25, 2016
Mylan NV Chief Executive Officer Heather Bresch Interview
Finance
Mylan CEO Blamed Obamacare for EpiPen Sticker Shock
By Jen WiecznerAugust 24, 2016
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Finance
Here’s Why Mylan Has Something to Be Happy About Today
By Lucinda ShenAugust 24, 2016
Democratic Presidential Nominee Hillary Clinton Delivers Speech On The Economy
Health
Pharma Bro Martin Shkreli Takes On Hillary Clinton Over Mylan’s EpiPen
By Sy MukherjeeAugust 24, 2016
A sign is seen at an AstraZeneca site in Macclesfield
Health
AstraZeneca Is Selling Its Antibiotics Business to Pfizer
By Reuters and Michelle TohAugust 24, 2016
Senator Amy Klobuchar, D-MN, listens to
Health
Lawmakers Are Demanding Investigations Into Mylan’s Huge EpiPen Price Hike
By Sy MukherjeeAugust 23, 2016
Amid debate on drug prices, California leads way on cost controls
Health
How Mylan Got Away With Its Enormous Price Hike for the EpiPen
By Sy MukherjeeAugust 22, 2016
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
Finance
Valeant Is Said to Be Hiring This Zoetis Exec as Its New CFO
By Reuters and Michelle TohAugust 22, 2016
Pfizer In Merger Talks With Allergan PLC
Finance
Pfizer ‘In Advanced Talks’ to Acquire Medivation for About $14 Billion
By Reuters and Michelle TohAugust 21, 2016
Republican Presidential Candidates Hold Third Debate In Colorado
Leadership
Why Donald Trump’s Anti-Trade Stance Worries Drug Companies
By Dylan Scott and STAT NewsAugust 20, 2016
1...
  • 67
  • 68
  • 69
  • 70
  • 71
...100
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Cybersecurity
OpenAI says its AI models secretly broke out of a secure test environment and hacked into AI company Hugging Face in order to cheat on an evaluationplaceholder alt text
By Jeremy Kahn and Emily ForliniJuly 21, 2026
AI
Mathematicians grapple with a ‘very rapid and very unsettling change’ as AI cracks yet another century-old problemplaceholder alt text
By Eva RoytburgJuly 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.